Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI
Active, not recruitingOBSERVATIONAL
Enrollment
63
Participants
Timeline
Start Date
June 30, 2015
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
Conditions
Screening Breast MRI in Patients Who Are BRCA Mutation Carriers
Interventions
DEVICE
MRI
BEHAVIORAL
Optional Screening Questionnaire
Trial Locations (1)
10065
Memorial Sloan Kettering Cancer Center, New York
All Listed Sponsors
lead
Memorial Sloan Kettering Cancer Center
OTHER
NCT02462460 - Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI | Biotech Hunter | Biotech Hunter